New survey: Voters seriously concerned about fine print in reconciliation bill

With a final vote in Congress expected on a reconciliation spending bill, a new Morning Consult survey explores what this legislation actually does – and does not do – and finds that voters are...
Read More
Myth vs. Fact: The Senate’s latest price setting proposal

The narratives being built around the Senate’s latest price setting proposal frame it as a bill intended to lower drug prices for patients and address rising inflation. But those narratives aren’t...
Read More
The Senate’s latest price setting proposal will undermine U.S. economic growth

Last week, we examined ways the latest drug pricing proposal will undermine patient access to medicines, American medical innovation and our health care system as a whole. But there is another...
Read More
Celebrating Medicare’s 57th anniversary

In case you missed it, Saturday, July 30, marked the anniversary of Medicare. For 57 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans...
Read More
New analysis finds deeper impact of drug pricing bill on biopharmaceutical researchers

A new analysis by the health care analytics and research firm Avalere reveals the partisan drug pricing bill will have a much deeper impact on the biopharmaceutical research industry than previously...
Read More
The Senate’s latest price setting proposal will undermine: Our health care system

Members of Congress continue to push a misguided drug pricing proposal under the guise of negotiation as part of the reconciliation package. This proposal is nothing short of government price setting...
Read More
The Senate’s latest price setting proposal will undermine: American medical innovation

Members of Congress continue to push a misguided drug pricing proposal under the guise of negotiation as part of the reconciliation package. This proposal is nothing short of government price setting...
Read More
The Senate’s latest price setting proposal will undermine: Patient access to medicines

Members of Congress continue to push a misguided drug pricing proposal under the guise of negotiation as part of the reconciliation package. This proposal is nothing short of government price setting...
Read More
The Patient Perspective: Government price-setting harms patients

Unfortunately, policymakers are again looking for bumper-sticker answers to the health care affordability challenges many Americans face, ignoring real commonsense solutions in exchange for flawed...
Read More
Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US

Our industry continues working to improve patient access and affordability for medicines at the state level. I recently had the opportunity to connect with PhRMA board member Mark Reisenauer,...
Read More